Cite
APA Citation
Snir, A., Kessel, A., Haj, T., Rosner, I., Rozenbaum, M., Slobodin, G., & Toubi, E. (n.d.). anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy. Annals of the rheumatic diseases, 70, A57–A58. http://access.bl.uk/ark:/81055/vdc_100137792441.0x000060